Struggling to Analyze Small Volume Samples with Conventional LC-MS?

Oct 25, 2016 | Blogs, Technology | 0 comments

The M3 MicroLC System is designed for scientists who are struggling to analyze small volume samples with conventional LC-MS and need to lower their limits of quantitation while maintaining throughput and robustness.

When designing the M3 MicroLC System, we focused on creating an easy-to-use LC that would make microflow LC simple – even for those new to the technique.

With the M3 MicroLC System you can:

  • Stop worrying about having enough sample for accurate quantitation with lower LLOQs
  • Reduce solvent usage from liters to milliliters
  • Have enough sample left over to run replicates to confirm results
  • Increase robustness and sample cleanliness with the trap-and-elute workflow

We are also pleased to announce that the MicroLC System is the recipient of the 2016 Instrument Business Outlook’s (IBO) Silver Analytical Instrument Industrial Design Award. Each year Instrument Business Outlook (IBO) announces their awards for excellence in the industrial design of analytical instruments, portable analytical instruments, and laboratory equipment. The winners of the 2016 Awards demonstrate how industrial design can improve a product’s functionality and the end user’s experience. Criteria include innovation, aesthetics, functionality and utility. Award candidates are chosen from the new products that IBO monitors through trade shows, trade publications, press releases and the Internet. Read more about this award >

Why SCIEX partners with experts around the world

Innovation in mass spectrometry does not happen in isolation. Some of the most impactful scientific advances emerge from highly specialized research communities – proteomics experts developing new peptide identification workflows, metabolomics researchers curating spectral databases, toxicologists building compound libraries, and biopharma scientists creating novel characterization methods.

Managing ADC characterization: The challenge of turning complexity into confidence

Unlike traditional monoclonal antibodies, ADCs combine an antibody backbone with linker chemistry and a cytotoxic payload. This multi-component architecture introduces overlapping layers of heterogeneity, including drug-to-antibody ratio (DAR) distributions, charge variants, post-translational modifications, and structural changes at both the intact and subunit levels. Across ADC development, these characteristics are considered critical quality attributes that must be characterized, understood, and monitored.

3 reasons ZT Scan DIA is changing the game in metabolomics

For years, metabolomics researchers have faced a frustrating reality: modern high-resolution mass spectrometers can detect tens of thousands of molecular features, yet only a fraction can be confidently identified. The challenge is no longer finding molecules. It is generating the high-quality MS/MS data needed to confidently assign structures and extract meaningful biological insights.

Posted by

0 Comments

Submit a Comment

Pin It on Pinterest

Share This

Share this post with your network